-
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Analysts
来源: Buzz FX / 03 2月 2025 04:31:09 America/New_York
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat February 3, 2025 Share Link copied to clipboard. Shares of Mirum Pharmaceuticals, Inc.
Read more...